News and Announcements
TUDI’s capital raise target is in sight – Offer closes soon
- Published May 02, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
TUDI has continued to have a fantastic response from both investors and future subscribers and wanted to say thank you to those that have contacted us with product ideas, and investor contacts. TUDI is committed to launching the most intelligent suburb property prediction tool and the positive feedback continues to motivate the team.
In the drive to ensure we launch with the best possible product for the market, we wanted to provide this update for you.
Investor interest picked up momentum in April, with the target of A$500,000 clearly in sight. A meeting with 20 overseas investors from Singapore generated significant interest in TUDI. Numerous discussions have also come off the back of TUDI’s successful pitch at Emergence 2019. It was great to see investors and prospective investors together on Tuesday night.
TUDI’s raise closes soon, so get in touch today.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
